Blue Owl Capital (NYSE:OWL) Price Target Lowered to $23.00 at Citizens Jmp

Blue Owl Capital (NYSE:OWL) had its target price dropped by Citizens Jmp from $26.00 to $23.00 in a note issued to investors on Tuesday,Benzinga reports. The firm presently has a “market outperform” rating on the stock. Citizens Jmp’s price target points to a potential upside of 147.71% from the stock’s current price.

Other research analysts have also recently issued research reports about the company. Citigroup reissued an “outperform” rating on shares of Blue Owl Capital in a research note on Tuesday, January 27th. Oppenheimer dropped their target price on Blue Owl Capital from $24.00 to $17.00 and set an “outperform” rating on the stock in a research note on Wednesday, March 4th. Barclays reaffirmed an “equal weight” rating and set a $11.00 target price (down from $15.00) on shares of Blue Owl Capital in a research report on Monday, March 2nd. Raymond James Financial reissued a “strong-buy” rating on shares of Blue Owl Capital in a report on Thursday, February 19th. Finally, Wolfe Research set a $20.00 price target on Blue Owl Capital in a research note on Wednesday, January 7th. Two equities research analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $17.69.

Blue Owl Capital Stock Performance

Shares of OWL stock opened at $9.29 on Tuesday. Blue Owl Capital has a 52-week low of $8.55 and a 52-week high of $21.88. The firm has a market capitalization of $14.43 billion, a PE ratio of 89.35, a PEG ratio of 0.77 and a beta of 1.15. The stock has a fifty day simple moving average of $12.69 and a two-hundred day simple moving average of $15.00.

Blue Owl Capital (NYSE:OWL) last released its earnings results on Thursday, February 5th. The company reported $0.27 earnings per share for the quarter, beating the consensus estimate of $0.22 by $0.05. Blue Owl Capital had a return on equity of 20.93% and a net margin of 2.75%.The firm had revenue of $701.47 million for the quarter, compared to the consensus estimate of $712.75 million. On average, sell-side analysts forecast that Blue Owl Capital will post 0.92 EPS for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the stock. Cresset Asset Management LLC grew its holdings in Blue Owl Capital by 1,345.0% during the third quarter. Cresset Asset Management LLC now owns 1,379,485 shares of the company’s stock worth $23,355,000 after acquiring an additional 1,284,021 shares during the period. Capital International Investors lifted its position in shares of Blue Owl Capital by 3.5% during the 3rd quarter. Capital International Investors now owns 62,726,334 shares of the company’s stock valued at $1,061,999,000 after acquiring an additional 2,141,873 shares during the period. Elevation Point Wealth Partners LLC grew its holdings in shares of Blue Owl Capital by 5,256.9% in the 3rd quarter. Elevation Point Wealth Partners LLC now owns 374,236 shares of the company’s stock worth $6,336,000 after acquiring an additional 367,250 shares during the period. Partners Group Holding AG lifted its stake in shares of Blue Owl Capital by 8.3% during the third quarter. Partners Group Holding AG now owns 1,940,155 shares of the company’s stock valued at $32,847,000 after buying an additional 149,292 shares during the period. Finally, Oppenheimer & Co. Inc. boosted its position in Blue Owl Capital by 185.2% during the third quarter. Oppenheimer & Co. Inc. now owns 136,956 shares of the company’s stock worth $2,319,000 after acquiring an additional 88,935 shares during the last quarter. Institutional investors and hedge funds own 35.85% of the company’s stock.

Blue Owl Capital Company Profile

Blue Owl Capital is a global alternative asset manager that focuses on private credit, direct lending and equity-related strategies for institutional investors. Headquartered in New York, the firm develops and manages a range of private markets products designed to provide capital solutions to middle-market and larger corporate borrowers, as well as liquidity and partnership arrangements with private equity firms and other alternative managers.

Its core activities include direct lending and credit strategies that provide senior, unitranche and other structured loan products to companies across industries.